Stock Markets May 20, 2026 10:06 AM

Senator Durbin Presses Health Secretary to Halt Relaxation of Flavoured Vape Rules

Durbin calls recent FDA moves 'short-sighted' and 'corrupt', citing Big Tobacco lobbying and a $10 million political donation

By Hana Yamamoto BTI

U.S. Senator Dick Durbin urged Health Secretary Robert F. Kennedy Jr. to oppose recent relaxations in federal regulation of flavoured vapes, arguing the changes favor major tobacco companies and put children at risk. The call follows a series of shifts at the U.S. Food and Drug Administration that include authorising fruit-flavoured vapes and proposals to let some products reach shelves prior to full scientific review, developments that have drawn concern from lawmakers and contributed to the resignation of an FDA commissioner.

Senator Durbin Presses Health Secretary to Halt Relaxation of Flavoured Vape Rules
BTI

Key Points

  • Senator Dick Durbin urged Health Secretary Robert F. Kennedy Jr. on May 20 to oppose easing of flavoured vape rules, calling recent changes "short-sighted" and "corrupt" due to industry lobbying.
  • The FDA has authorised fruit-flavoured vapes for sale and proposed allowing some vapes and nicotine pouches on shelves before agency scientists complete inspections, relaxing the requirement that manufacturers prove a public health benefit prior to market access.
  • Durbin and nine other senators wrote to acting FDA Commissioner Kyle Diamantas on May 15 requesting rescission of marketing authorisations for fruit-flavoured vapes; the developments have prompted discussion about political influence and coincided with the resignation of Commissioner Marty Makary.

May 20 - U.S. Senator Dick Durbin on Wednesday wrote to Health Secretary Robert F. Kennedy Jr., urging him to resist policy changes that would ease federal controls on flavoured vaping products. In his letter, Durbin characterised recent regulatory shifts as short-sighted and influenced by industry lobbying, saying they "benefit Big Tobacco at the expense of our nation’s children."

The appeal comes amid a noticeable softening of the U.S. Food and Drug Administration's approach to certain nicotine products. In recent weeks the agency has authorised fruit-flavoured vapes for sale for the first time and set out proposals to permit some vapes and nicotine pouches to appear on retail shelves before agency scientists have completed their inspections. That approach relaxes a long-standing requirement that manufacturers prove their products provide a net public health benefit before being authorised for sale.

Those regulatory shifts have had immediate institutional consequences. The moves were a factor in the resignation of Commissioner Marty Makary and have intensified debate about possible political influence within the FDA. Durbin and other critics say the changes reflect pressure from the White House and the tobacco industry.

Views remain divided about the public health implications of flavoured nicotine products. Representatives of the nicotine industry and some researchers maintain that flavoured vapes and nicotine pouches can assist smokers in quitting combustible cigarettes. Opponents, including Durbin, counter that such products are particularly appealing to young people and risk creating new patterns of nicotine addiction, which they believe warrants stringent controls.

In addition to his letter to Health Secretary Kennedy, Durbin was among ten senators who signed a May 15 letter to acting FDA Commissioner Kyle Diamantas urging him to rescind marketing authorisations for fruit-flavoured vapes. Durbin described the regulatory changes as "corrupt," attributing undue influence to industry lobbying efforts.

Durbin's communication also drew attention to recent political spending by tobacco companies. He noted that the U.S. unit of British American Tobacco contributed $10 million to a Trump-aligned super PAC in 2024, citing Federal Election Commission data. The company did not provide an immediate response to requests for comment; the U.S. unit, Reynolds American, also did not immediately respond to a request for comment.

The White House and the Department of Health and Human Services, which oversees the FDA, did not immediately respond to requests for comment on Durbin's letter or the FDA's recent policy adjustments.


Context in brief

  • The FDA authorised fruit-flavoured vapes for sale and proposed allowing some products on shelves prior to scientific inspection.
  • Durbin urged Health Secretary RFK Jr. to resist these changes, calling them short-sighted and corrupt due to industry lobbying.
  • Durbin and nine other senators asked acting FDA Commissioner Kyle Diamantas on May 15 to rescind marketing authorisations for fruit-flavoured vapes.

Risks

  • Potential politicisation of FDA decision-making - could affect regulatory oversight across the healthcare and consumer nicotine sectors.
  • Increased youth appeal and risk of new nicotine addiction if flavoured products remain more widely available - relevant to public health and consumer goods markets.
  • Industry lobbying and large political donations by tobacco companies may influence regulatory outcomes - a risk to predictable regulatory frameworks for the tobacco and vaping industries.

More from Stock Markets

Toronto market ends at fresh record as healthcare, financials and materials lead gains Jun 4, 2026 After-Hours Movers: Lululemon Dips on Guidance as Software and Data Names Show Mixed Reactions Jun 4, 2026 Lululemon Lowers Fiscal 2026 Revenue and EPS Guidance as U.S. Demand Softens Jun 4, 2026 Anthropic Places Engineers Inside NSA to Support Mythos AI for Offensive Cyber Tasks Jun 4, 2026 Trump Directs $700M Toward Coal Industry, Lifting Peabody Shares Jun 4, 2026